Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Blood Marker Shows Promise for Tracking Oxaliplatin-Related Nerve Damage

A research team has found preliminary evidence that a blood-based marker of nerve injury could help researchers track peripheral neurotoxicity caused by oxaliplatin, a chemotherapy drug used to treat colorectal cancer. In a study of 28 patients, serum neurofilament light chain (sNfL) increased during treatment and remained elevated three months afterward, alongside worsening neuropathy assessments. Higher follow-up concentrations were associated with more severe clinical signs and patient-reported symptoms. The findings suggest that sNfL could complement existing assessments in trials evaluating interventions to prevent chemotherapy-related nerve damage, providing an objective measure of changes in nerve injury.

November 9, 2026


November 15 2026

November 13 2026

November 12 2026

November 11 2026

November 10 2026

November 9 2026

November 8 2026

November 7 2026

November 6 2026

November 5 2026

November 4 2026

November 3 2026

November 2 2026

November 1 2026